Yoshie K, Fujita Y, Moriya A, Kawana I, Miyamoto K, Umemura S
Second Department of Internal Medicine, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama City 236-004, Japan.
Eur J Gastroenterol Hepatol. 2001 Sep;13(9):1111-3. doi: 10.1097/00042737-200109000-00020.
A 56-year-old man developed severe lower gastrointestinal bleeding. He was classified as Child-Pugh grade C. Colonoscopy revealed multiple angiodysplasia-like lesions and mucosal friability throughout the entire colon (portal hypertensive colopathy, PHC). Haemostasis was immediately achieved with octreotide treatment, although melaena recurred after discontinuation of the infusion. Propranolol treatment before discontinuation of octreotide infusin prevented the recurrence of bleeding from PHC. Octreotide is a safe and effective treatment for severe acute bleeding from PHC, especially if the patient is not a candidate for transjugular intrahepatic portosystemic shunt (TIPS) or treatment with a beta-blocker due to the severity of liver disease or haemodynamic instability. However, a sufficient reduction of portal pressure by propranolol or other medical treatment may be needed in order to discontinue octreotide infusion without the recurrence of bleeding.
一名56岁男性出现严重下消化道出血。他被归类为Child-Pugh C级。结肠镜检查发现整个结肠有多个血管发育异常样病变和黏膜脆性增加(门静脉高压性结肠病,PHC)。尽管停止输注后黑便复发,但奥曲肽治疗立即实现了止血。在停止奥曲肽输注前使用普萘洛尔治疗可预防PHC出血复发。奥曲肽是治疗PHC严重急性出血的安全有效方法,特别是如果患者因肝病严重程度或血流动力学不稳定而不适合经颈静脉肝内门体分流术(TIPS)或β受体阻滞剂治疗。然而,为了在不复发出血的情况下停止奥曲肽输注,可能需要通过普萘洛尔或其他药物治疗充分降低门静脉压力。